Abstract
The authors wish to make the following corrections to their article:
Corrigendum
The authors regret that there are errors in their original paper.
The following shows where original text has been removed (strikethrough) and new wording introduced (underlined).
Page 2, ‘Introduction’ section
RCI is the onlyremains the only other therapy indicated for the treatment of acute exacerbations of MS in adults by the US Food and Drug Administration.8
Page 4, ‘Discussion’ section
RCI is the onlyremains the only other treatment indicated for the treatment of acute exacerbations of MS in adults by the US Food and Drug Administration.8